Duloxetine may also offer a new treatment option for patients with neuropathic pain or stress urinary incontinence. These indications, although seemingly dissimilar, have strong relationships to ...

Duloxetine is the first drug to gain FDA approval for the indication of diabetic peripheral neuropathic pain. However, randomized controlled clinical trials of duloxetine for this indication have ...

AS July gets off to a sunny start, many of us are out and about enjoying the weather at festivals, village fetes and garden ...

The overall chronic lower back pain market is expected to boost with the expected launch of emerging therapies such as SP-102 (Scilex Holding), ...

The Global Fibromyalgia Treatment Market is expected to reach at a CAGR of 4.2 % during the forecast period 2025-2033. The ...

Osteoarthritis is usually a disease experienced by individuals during their aging process, but things are not quite so simple, and much more encouraging. Generally more than 32 million adults in the U ...

REGIONS NEWS Oral presentation on study demonstrating the ability of sotagliflozin to reduce the risk of hypoglycemic events regardless of kidney function in people with type 1 diabetes THE WOODLANDS, ...

Now, researchers at Weill Cornell Medicine and the Burke Neurological Institute may have found a solution. They have developed a new drug that could ease nerve pain without the dangerous side effects ...

Type 2 diabetes is a long-term condition where the body can’t use insulin properly, causing blood sugar levels to stay too ...

The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

Our furry friends feel pain just like we do. But how, as a pet owner, can you help them feel better? Here's guidance, ...

A groundbreaking wireless implant promises real-time, personalized pain relief using AI and ultrasound power no batteries, no ...